title: Neuroendocrine Tumors--Current and Future Clinical Advances.
authors.affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02115, USA. Electronic address: jang@partners.org.
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Chan
authors.affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02115, USA. Electronic address: Matthew_Kulke@dfci.harvard.edu.
authors.forename: Matthew H
authors.initials: MH
authors.lastname: Kulke
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis / Q000235:genetics; D003131:Combined Modality Therapy / Q000379:methods / Q000639:trends; D018572:Disease-Free Survival; D005544:Forecasting; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D057054:Molecular Imaging / Q000379:methods* / Q000639:trends; D058990:Molecular Targeted Therapy / Q000379:methods* / Q000639:trends; D009154:Mutation; D018358:Neuroendocrine Tumors / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy*
chemical_list: D014408:Biomarkers, Tumor